Partner Dr Luke Kempton leads Wragge & Co life sciences team in licensing agreement
Wragge & Co’s life sciences team has brokered a licensing agreement between AstraZeneca and a partnership of Belgian life sciences research institutes: the Biotechnology Institute VIB, CD3 and KU Leuven.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Wragge Lawrence Graham & Co
News from The Lawyer
Briefings from Wragge Lawrence Graham & Co
There is often confusion as to what exactly a net contribution clauses is, and its effect in a construction contract. In this article, Wragges sets out the basics and address some of the common misconceptions in this area.
Ruling on an application for specific disclosure could have big implications in the early stages of procurement disputes.